---
title: "Danaher Corporation (DHR.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/DHR.US.md"
symbol: "DHR.US"
name: "Danaher Corporation"
industry: "生命科学工具与服务"
---

# Danaher Corporation (DHR.US)

| Item | Detail |
|------|--------|
| Industry | 生命科学工具与服务 |
| Location | 美股市场 |
| Website | [www.danaher.com](https://www.danaher.com) |

## Company Profile

丹纳赫公司在美国、中国及国际市场设计、制造和销售专业、医疗、研究和工业产品及服务。其业务分为生物技术、生命科学和诊断三个部门。生物技术部门提供生物加工技术、耗材、服务和解决方案，以推动、加速和整合治疗药物的开发和生产；细胞系和细胞培养基开发服务；用于生产的细胞培养基、工艺液体和缓冲液；色谱树脂、过滤技术和无菌灌装；一次性硬件、耗材和服务，如全套生产设施的设计和安装；实验室过滤、分离和纯化；实验室规模的蛋白质纯化和分析工具；用于诊断和检测开发的试剂、膜和服务；以及医疗过滤解决方案。生命科学部门提供质谱仪；生物分析测量系统；流式细胞术、基因组学、实验室自动化、离心、液体处理自动化仪器、抗体以及颗粒...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-16T04:30:13.000Z

**Overall: C (0.46)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 13 / 60 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 2.90% |  |
| Net Profit YoY | -7.31% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 2.86 |  |
| Dividend Ratio | 0.60% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 150.27B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 24.57B |  |


**Multi Score**: C

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 7.05% | C |
| Profit Margin | 14.71% | B |
| Gross Margin | 59.11% | B |

#### Growth Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 2.90% | C |
| Net Profit YoY | -7.31% | C |
| Total Assets YoY | 7.64% | B |
| Net Assets YoY | 6.04% | B |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 679.80% | C |
| OCF YoY | 2.90% | C |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.31 | D |

#### Debt Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 37.05% | B |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Danaher Corporation",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "7.05%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "14.71%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "59.11%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "C",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "2.90%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-7.31%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "7.64%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "6.04%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "679.80%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "2.90%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.31",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "B",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "37.05%",
          "rating": "B"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | ChromaDex (US.CDXC) | A | A | A | B | B | A |
| 02 | 安捷伦科技 (US.A) | A | C | B | C | C | B |
| 03 | 沃特世 (US.WAT) | A | B | B | C | C | B |
| 04 | 药明生物(ADR) (US.WXXWY) | B | B | D | A | B | B |
| 05 | 西氏医药服务 (US.WST) | B | B | B | B | C | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 41.58 | 17/59 | 44.89 | 41.43 | 37.47 |
| PB | 2.86 | 32/59 | 3.08 | 2.88 | 2.72 |
| PS (TTM) | 6.12 | 42/59 | 6.47 | 6.15 | 5.84 |
| Dividend Yield | 0.60% | 4/59 | 0.60% | 0.57% | 0.54% |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-13T05:00:00.000Z

Total Analysts: **26**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 18 | 69% |
| Overweight | 4 | 15% |
| Hold | 3 | 12% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 212.58 |
| Highest Target | 310.00 |
| Lowest Target | 220.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/DHR.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/DHR.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/DHR.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.
